drugset / Trial / NCT00979134
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
NaSingle-groupOpen-labelTreatment
Summary
This study is primarily designed to assess the safety and tolerability of AZD4547 at increasing doses in patients with advanced solid malignancies and for whom no standard medication options are available. It also assesses the blood levels and action of AZD4547 in the body over a period of time.
Timeline
- Start
- 2009-10-21
- Primary completion
- 2014-02-12
- Completion
- 2015-03-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fexagratinib | Small molecule | 80 mg | Oral |